Castle Biosciences Reports Second Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 22c; Offers FY23 Revenue Guidance
August 2, 2023 4:25 PM EDTCastle Biosciences Inc. (NASDAQ: CSTL) reported Q2 EPS of ($0.70), $0.22 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $50.14 million versus the consensus estimate of $44.24 million.
GUIDANCE:
Castle Biosciences Inc. sees FY2023 revenue of $180 million, versus the... More
